Helena I. Boshoff

15.6k total citations · 2 hit papers
171 papers, 11.2k citations indexed

About

Helena I. Boshoff is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Helena I. Boshoff has authored 171 papers receiving a total of 11.2k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Infectious Diseases, 111 papers in Molecular Biology and 70 papers in Epidemiology. Recurrent topics in Helena I. Boshoff's work include Tuberculosis Research and Epidemiology (108 papers), Mycobacterium research and diagnosis (54 papers) and Biochemical and Molecular Research (46 papers). Helena I. Boshoff is often cited by papers focused on Tuberculosis Research and Epidemiology (108 papers), Mycobacterium research and diagnosis (54 papers) and Biochemical and Molecular Research (46 papers). Helena I. Boshoff collaborates with scholars based in United States, United Kingdom and South Africa. Helena I. Boshoff's co-authors include Clifton E. Barry, Valerie Mizrahi, Ujjini H. Manjunatha, Dirk Schnappinger, Thomas Dick, Courtney C. Aldrich, Sabine Ehrt, Véronique Dartois, Douglas B. Young and Brent R. Copp and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Helena I. Boshoff

166 papers receiving 11.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The spectrum of latent tuberculosis: rethinking the biology and intervention strategies

2009 1.0k citations Clifton E. Barry, Helena I. Boshoff et al. profile →
SQ109 Targets MmpL3, a Membrane Transporter of Trehalose Monomycolate Involved in Mycolic Acid Donation to the Cell Wall Core of Mycobacterium tuberculosis

2012 381 citations Kapil Tahlan, Clifton E. Barry et al. Antimicrobial Agents and Chemotherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Helena I. Boshoff United States	56	6.8k	5.7k	4.6k	2.0k	1.5k	171	11.2k
Laurent Kremer France	62	7.5k 1.1×	4.9k 0.8×	7.2k 1.6×	2.4k 1.2×	1.3k 0.8×	292	13.1k
Mary Jackson United States	63	5.8k 0.9×	5.1k 0.9×	5.1k 1.1×	1.6k 0.8×	1.0k 0.7×	225	11.0k
Véronique Dartois United States	56	6.6k 1.0×	3.8k 0.7×	4.7k 1.0×	786 0.4×	900 0.6×	202	10.2k
Mamadou Daffé France	63	7.6k 1.1×	5.3k 0.9×	7.5k 1.6×	1.7k 0.8×	1.3k 0.8×	191	12.6k
Thomas Dick Singapore	49	5.4k 0.8×	3.8k 0.7×	4.4k 0.9×	942 0.5×	1.1k 0.7×	201	8.5k
Tanya Parish United States	50	5.0k 0.7×	4.0k 0.7×	3.8k 0.8×	807 0.4×	939 0.6×	195	7.8k
Koen Andries Belgium	62	10.1k 1.5×	5.5k 1.0×	6.3k 1.4×	2.0k 1.0×	1.1k 0.7×	156	14.2k
Michael McNeil United States	72	4.9k 0.7×	7.2k 1.3×	4.7k 1.0×	4.0k 2.0×	873 0.6×	218	15.8k
Dirk Schnappinger United States	49	7.0k 1.0×	5.5k 1.0×	5.3k 1.1×	410 0.2×	1.5k 1.0×	115	11.1k
Catherine Vilchèze United States	46	3.6k 0.5×	3.3k 0.6×	2.6k 0.6×	872 0.4×	862 0.6×	85	6.3k

Countries citing papers authored by Helena I. Boshoff

Since Specialization

Citations

This map shows the geographic impact of Helena I. Boshoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helena I. Boshoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helena I. Boshoff more than expected).

Fields of papers citing papers by Helena I. Boshoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helena I. Boshoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helena I. Boshoff. The network helps show where Helena I. Boshoff may publish in the future.

Co-authorship network of co-authors of Helena I. Boshoff

This figure shows the co-authorship network connecting the top 25 collaborators of Helena I. Boshoff. A scholar is included among the top collaborators of Helena I. Boshoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helena I. Boshoff. Helena I. Boshoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ramón‐García, Santiago, Helena I. Boshoff, Joaquín Rullás, et al.. (2025). Sanfetrinem, an oral β-lactam antibiotic repurposed for the treatment of tuberculosis. Drug Resistance Updates. 80. 101213–101213. 2 indexed citations

Birangal, Sumit, et al.. (2022). Molecular insights into Mmpl3 lead to the development of novel indole-2-carboxamides as antitubercular agents. Molecular Systems Design & Engineering. 7(6). 592–606. 5 indexed citations

Evans, Joanna C., John Post, V. Mendes, et al.. (2021). Targeting Mycobacterium tuberculosis CoaBC through Chemical Inhibition of 4′-Phosphopantothenoyl-l-cysteine Synthetase (CoaB) Activity. ACS Infectious Diseases. 7(6). 1666–1679. 6 indexed citations

Oh, Sangmi, M. Daben J. Libardo, Shaik Azeeza, et al.. (2021). Structure–Activity Relationships of Pyrazolo[1,5-a]pyrimidin-7(4H)-ones as Antitubercular Agents. ACS Infectious Diseases. 7(2). 479–492. 13 indexed citations

Thomas, S.E., Andrew Whitehouse, Karen Brown, et al.. (2020). Fragment-based discovery of a new class of inhibitors targeting mycobacterial tRNA modification. Nucleic Acids Research. 48(14). 8099–8112. 18 indexed citations

Wang, Zhe, Vijay Soni, Gwendolyn A. Marriner, et al.. (2019). Mode-of-action profiling reveals glutamine synthetase as a collateral metabolic vulnerability of M. tuberculosis to bedaquiline. Proceedings of the National Academy of Sciences. 116(39). 19646–19651. 32 indexed citations

Bockman, Matthew R., Curtis A. Engelhart, Neeraj K. Mishra, et al.. (2019). Investigation of (S)-(−)-Acidomycin: A Selective Antimycobacterial Natural Product That Inhibits Biotin Synthase. ACS Infectious Diseases. 5(4). 598–617. 26 indexed citations

Wang, Xu, Rachel L. Edwards, Claire Johnson, et al.. (2018). MEPicides: α,β-Unsaturated Fosmidomycin Analogues as DXR Inhibitors against Malaria. Journal of Medicinal Chemistry. 61(19). 8847–8858. 27 indexed citations

Boshoff, Helena I., Vinayak Singh, Davide M. Ferraris, et al.. (2018). Expanding Benzoxazole-Based Inosine 5′-Monophosphate Dehydrogenase (IMPDH) Inhibitor Structure–Activity As Potential Antituberculosis Agents. Journal of Medicinal Chemistry. 61(11). 4739–4756. 28 indexed citations

10.

Boshoff, Helena I., et al.. (2018). Chemical constituents and antimycobacterial studies of the leaf extracts of Pavetta crassipes K. Schum. SHILAP Revista de lepidopterología. 5(1). 88–95. 3 indexed citations

11.

Sarathy, Jansy P., Laura E. Via, Dominique J. Wiener, et al.. (2017). Extreme Drug Tolerance of Mycobacterium tuberculosis in Caseum. Antimicrobial Agents and Chemotherapy. 62(2). 159 indexed citations

12.

Boshoff, Helena I., et al.. (2016). SAR and identification of 2-(quinolin-4-yloxy)acetamides as Mycobacterium tuberculosis cytochrome bc ₁ inhibitors. MedChemComm. 7(11). 2122–2127. 35 indexed citations

13.

Kim, Jee-Hyun, Kathryn O’Brien, Ritu Sharma, et al.. (2013). A genetic strategy to identify targets for the development of drugs that prevent bacterial persistence. Proceedings of the National Academy of Sciences. 110(47). 19095–19100. 102 indexed citations

14.

Kaiser, Marcel, et al.. (2012). Synthesis and antimalarial and antituberculosis activities of a series of natural and unnatural 4-methoxy-6-styryl-pyran-2-ones, dihydro analogues and photo-dimers. Bioorganic & Medicinal Chemistry. 20(4). 1482–1493. 52 indexed citations

15.

Gurumurthy, Meera, Tathagata Mukherjee, Cynthia S. Dowd, et al.. (2011). Substrate specificity of the deazaflavin‐dependent nitroreductase from Mycobacterium tuberculosis responsible for the bioreductive activation of bicyclic nitroimidazoles. FEBS Journal. 279(1). 113–125. 71 indexed citations

16.

Boshoff, Helena I. & Kapil Tahlan. (2010). Mechanisms underlying mycobacterial infections. Drug Discovery Today Disease Mechanisms. 7(1). e1–e3. 1 indexed citations

17.

Singh, Ramandeep, Clifton E. Barry, & Helena I. Boshoff. (2010). The Three RelE Homologs of Mycobacterium tuberculosis Have Individual, Drug-Specific Effects on Bacterial Antibiotic Tolerance. Journal of Bacteriology. 192(5). 1279–1291. 112 indexed citations

18.

Hugonnet, Jean‐Emmanuel, L.W. Tremblay, Helena I. Boshoff, Clifton E. Barry, & John S. Blanchard. (2009). Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis. Science. 323(5918). 1215–1218. 382 indexed citations

19.

Singh, Ramandeep, Ujjini H. Manjunatha, Helena I. Boshoff, et al.. (2008). PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release. Science. 322(5906). 1392–1395. 491 indexed citations

20.

Boshoff, Helena I., Timothy G. Myers, Brent R. Copp, et al.. (2004). The Transcriptional Responses of Mycobacterium tuberculosis to Inhibitors of Metabolism. Journal of Biological Chemistry. 279(38). 40174–40184. 474 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact